Search

Nucera, Carmelo. 2019. “A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer.”. Oncotarget 10 (7): 686-87.

Antonello, Zeus A, Nancy Hsu, Manoj Bhasin, Giovanni Roti, Mukta Joshi, Paul Van Hummelen, Emily Ye, et al. 2017. “Vemurafenib-Resistance via de Novo RBM Genes Mutations and Chromosome 5 Aberrations Is Overcome by Combined Therapy With Palbociclib in Thyroid Carcinoma With BRAFV600E.”. Oncotarget 8 (49): 84743-60.

Mehrzad, Raman, Michiya Nishino, Carmelo Nucera, Dora Dias-Santagata, James Hennessey V, and Per-Olof Hasselgren. 2017. “Invasive Follicular Variant of Papillary Thyroid Cancer Harboring the NRAS Mutation Q61K and Presenting With Bone Metastasis-A Case Report.”. International Journal of Surgery Case Reports 38: 180-84.

Daniell, Kayla, and Carmelo Nucera. 2016. “Effect of the Micronutrient Iodine in Thyroid Carcinoma Angiogenesis.”. Aging 8 (12): 3180-84.

Nucera, Carmelo. 2016. “Evolution of Resistance to Thyroid Cancer Therapy.”. Aging 8 (8): 1576-7.

Sadow, Peter M, Dora Dias-Santagata, Zongli Zheng, Derrick T Lin, Long Phi Le, and Carmelo Nucera. 2015. “Identification of Insertions in PTEN and TP53 in Anaplastic Thyroid Carcinoma With Angiogenic Brain Metastasis.”. Endocrine-Related Cancer 22 (6): L23-8.

Kovach, Alexandra E, Carmelo Nucera, Quynh T Lam, Ahnthu Nguyen, Dora Dias-Santagata, and Peter M Sadow. 2015. “Genomic and Immunohistochemical Analysis in Human Adrenal Cortical Neoplasia Reveal Beta-Catenin Mutations As Potential Prognostic Biomarker.”. Discoveries (Craiova, Romania) 3 (2).

Bucur, Octavian, Alexandru Almasan, Barbara S Nikolajczyk, Garth L Nicolson, Jack Lawler, Victor E Velculescu, Sorin Draghici, et al. 2013. “Discoveries: an Innovative Platform for Publishing Cutting-Edge Research Discoveries in Medicine, Biology and Chemistry.”. Discoveries (Craiova, Romania) 1 (1): e1.

Duquette, Mark, Peter M Sadow, Jack Lawler, and Carmelo Nucera. 2013. “Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment.”. Frontiers in Endocrinology 4: 189.

Bellelli, Roberto, Maria Domenica Castellone, Ginesa Garcia-Rostan, Clara Ugolini, Carmelo Nucera, Peter M Sadow, Tito Claudio Nappi, et al. 2012. “FOXM1 Is a Molecular Determinant of the Mitogenic and Invasive Phenotype of Anaplastic Thyroid Carcinoma.”. Endocrine-Related Cancer 19 (5): 695-710.